Skip to content

Trial Evaluating Hedonic vs Cash Incentives

Trial Evaluating Hedonic vs Cash Incentives

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04618757
Acronym
TEH-C
Enrollment
310
Registered
2020-11-06
Start date
2022-11-18
Completion date
2023-08-31
Last updated
2023-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Physical Activity

Brief summary

This study aims to determine, using a randomized trial with two parallel arms, whether hedonic rewards (Arm 1) can be more effective than their cash equivalent (Arm 2) in motivating participants to meet step goals.

Detailed description

The evidence is overwhelming that sustained physical activity reduces risks for non-communicable diseases, increases longevity, and reduces medical costs. Yet, the rates of physical activity have been steadily decreasing such that physical inactivity is now the fourth leading cause of death worldwide. In Singapore, 33% of adults are insufficiently active despite Singapore being a highly walkable city with numerous subsidized community-based physical activity programs. A review of the literature shows that, to date, no study has directly compared cash versus hedonic rewards for health behavior change despite theory suggesting hedonic rewards may work better. Furthermore, hedonic rewards can often be purchased at lower cost than their cash equivalent. This makes hedonic rewards potentially more cost-effective if they are proven to be at least as effective at increasing positive behavior change compared to giving the same value in cash. Thus, we aim to determine, using a randomized trial with two parallel arms, whether hedonic rewards (Arm 1) can be more effective than their cash equivalent (Arm 2) in promoting increases in physical activity, assessed via step counts measured by a Fitbit physical activity tracker, during a 4-calendar month intervention. We hypothesize that the average proportion of months meeting the incentivized step target across participants will be greater for those in the hedonic incentive arm as compared to those in the cash incentive arm (primary outcome).

Interventions

BEHAVIORALHedonic Reward

A reimbursement credit for hedonic expenses worth up to $50 will be awarded to each participant if they log at least 10,000 daily steps on at least 25 days during the first 28 days of each calendar month on Fitbit activity trackers provided by the study.

BEHAVIORALCash Reward

A reimbursement credit for $50 in cash will be awarded to each participant if they log at least 10,000 daily steps on at least 25 days during the first 28 days of each calendar month on Fitbit activity trackers provided by the study.

DEVICEFitbit

Fitbit devices are wireless pedometers that track the steps of participants, and will be offered in conjunction with a tailored website with customized information for participants.

Sponsors

Duke-NUS Graduate Medical School
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Aged between 21 to 70 years inclusive. * Singapore resident (residing in Singapore during the study period \[up to 5 months\]) * English-speaking and English literate * Smartphone-literate

Exclusion criteria

* Pregnant or lactating * Unable to walk up 10 steps (individual steps, not floors) without stopping * Currently on doctor's advice against engaging in moderate-to-vigorous physical activity (i.e., brisk walking or more intense). * Currently have a condition(s) that restricts engaging in moderate-to-vigorous physical activity (i.e., brisk walking or more intense). * Unwilling to be randomized into study arms * Unwilling to use a Fitbit for the study period (up to 5 calendar months) * Unwilling to pay the $20 enrolment fee * Does not complete the Consent Form * Refuses to give consent to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Proportion of months in meeting the step targetMonths 1-4The mean proportion of months meeting the incentivized targets (i.e. at least 10,000 daily steps on at least 25 days during the first 28 days of each calendar month via step counts measured by Fitbit, during a 4 calendar month intervention) across participants.

Secondary

MeasureTime frameDescription
Difference in mean daily steps between the 2 intervention armsMonths 1-4Difference in mean daily steps between intervention arms for the first 28 days of each of 4 intervention months, controlling for baseline daily values. These will be measured via step counts measured by Fitbit.
Difference in median daily steps between the 2 intervention armsMonths 1-4Difference in median daily steps between intervention arms for the first 28 days of each of 4 intervention months, controlling for baseline daily values. These will be measured via step counts measured by Fitbit.
Difference in mean Fitbit fairly and very active minutes between the 2 intervention armsMonths 1-4Difference in mean Fitbit fairly and very active minutes between intervention arms for the first 28 days of each of 4 intervention months, controlling for baseline daily values. The Fitbit fairly and active minutes count towards Fitbit active minutes, which are determined by Fitbit's proprietary algorithms and are defined as sustained activity of ≥10-minute bouts. These will be measured via step counts measured by Fitbit.
Difference in median Fitbit fairly and very active minutes between the 2 intervention armsMonths 1-4Difference in median Fitbit fairly and very active minutes between intervention arms for the first 28 days of each of 4 intervention months, controlling for baseline daily values. The Fitbit fairly and active minutes count towards Fitbit active minutes, which are determined by Fitbit's proprietary algorithms and are defined as sustained activity of ≥10-minute bouts. These will be measured via step counts measured by Fitbit

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026